Dossier
early-stage assets
Coverage of early-stage assets in the Nexus archive.
- Patent cliffs aren’t the only driver of the biotech M&A boom
The biotech M&A boom is being driven by factors beyond patent cliffs, with many deals this year targeting early-stage assets.